D.E. Shaw & Co
RVMDW icon

D.E. Shaw & Co’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

D.E. Shaw & Co’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.75M Buy
1,580,345
+125,450
+9% +$243K ﹤0.01% 2672
2025
Q4 		$1.37M Hold
1,454,895
– – ﹤0.01% 3333
2025
Q3 		$436K Hold
1,454,895
– – ﹤0.01% 3928
2025
Q2 		$393K Hold
1,454,895
– – ﹤0.01% 3744
2025
Q1 		$55.3K Hold
1,454,895
– – ﹤0.01% 4058
2024
Q4 		$235K Buy
1,454,895
+107,456
+8% +$31.8K ﹤0.01% 4007
2024
Q3 		$189K Hold
1,347,439
– – ﹤0.01% 4174
2024
Q2 		$96.1K Hold
1,347,439
– – ﹤0.01% 4170
2024
Q1 		$216K Hold
1,347,439
– – ﹤0.01% 3894
2023
Q4 		$445K Buy
+1,347,439
New +$602K ﹤0.01% 3566

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $196M AUM 84.21% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

D.E. Shaw & Co's RVMDW Position: Q1 2026 in Review

D.E. Shaw & Co increased its Revolution Medicines Inc Warrant (RVMDW) stake by 8.6% in Q1 2026, buying an estimated $243K and bringing the position to 1,580,345 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2672.

D.E. Shaw & Co first reported a position in RVMDW in Q4 2023 and has held it in 10 quarters since. 23 funds tracked by Wall St. Rank hold RVMDW as of Q1 2026.

  • D.E. Shaw & Co held 1,580,345 shares of Revolution Medicines Inc Warrant worth $2.75M as of Q1 2026.
  • D.E. Shaw & Co bought 125,450 Revolution Medicines Inc Warrant shares in Q1 2026, an estimated $243K.
  • Revolution Medicines Inc Warrant made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2672 holding.
  • D.E. Shaw & Co first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 10 quarters since.
  • 23 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.